<DOC>
	<DOC>NCT02159651</DOC>
	<brief_summary>This study is to evaluate the safety and the efficacy of Prograf in patients with interstitial pneumonia associated with polymyositis / dermatomyositis in acute clinical setting.</brief_summary>
	<brief_title>A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Dermatomyositis</mesh_term>
	<mesh_term>Polymyositis</mesh_term>
	<mesh_term>Lung Diseases, Interstitial</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Hospitalized patient Patient diagnosed with Interstitial pneumonia associated with polymyositis/dermatomyositis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>tacrolimus</keyword>
	<keyword>interstitial pneumonia</keyword>
	<keyword>prograf</keyword>
</DOC>